4 employees
Amber Therapeutics develops the next-generation of bioelectrical therapies.
2021
$1.3M
from 3 investors over 3 rounds
Amber Therapeutics raised undisclosed on January 24, 2023
Investors: Oxford Sciences Innovation and 8VC
Amber Therapeutics raised $1.3M on November 29, 2022
Investors: Innovate UK